Fulltext
Full text is available in PDF.
International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
The Construction and Validation of a New Ovarian Malignancy Probability Score (OMPS) for Prediction of Ovarian Malignancy
Author(s):
1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Epidemiology and Biostatistics School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Arash Hospital. Tehran University of Medical Sciences, Tehran, Iran
Published online:Sep 30, 2010
Article type:Research Article
Received:Jan 13, 2010
Accepted:May 21, 2010
How to Cite: Arab M, Yaseri M, Farzaneh M, Moridi A, Tehranian A, et al. The Construction and Validation of a New Ovarian Malignancy Probability Score (OMPS) for Prediction of Ovarian Malignancy. Int J Cancer Manag. 2010;3(3):e80701. doi:
Abstract
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
6
Jan
2019
Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer
Zinatossadat Bouzari,
Hadiseh Rahimi,
Hemmat Gholinia,
Shahla Yazdani,
Karimollah Hajian-Tilaki,
Mohammad Jafar Soleimani
Bouzari Z, Rahimi H, Gholinia H, Yazdani S, Hajian-Tilaki K, et al. Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer. Int J Cancer Manag. 2019;12(1):e59395. doi: https://doi.org/10.5812/ijcm.59395
17
Dec
2018
A Survey on the Role of Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), and Risk of Malignancy Index (RMI) in Pelvic Mass
Mojgan Karimi–Zarchi,
Nadereh Behtash,
Azamsadat Mousavi,
Fazemeh Ghaem Maghami,
Mitra Moddares Gilani,
Zohreh Chiti
,et al.Karimi–Zarchi M, Behtash N, Mousavi A, Ghaem Maghami F, Moddares Gilani M, et al. A Survey on the Role of Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), and Risk of Malignancy Index (RMI) in Pelvic Mass. Int J Cancer Manag. 2018;11(12):e79189. doi: https://doi.org/10.5812/ijcm.79189
12
May
2018
The Diagnostic Value of Serum CEA, CA-125, and ROMA Index in Low-Grade Serous Ovarian Cancer
Haniyeh Bashizadeh-Fakhar,
Mostafa Rezaie-Tavirani,
Hakimeh Zali,
Roya Faraji,
Ehsan Kazem Nejad,
Mohamadhossein Aghazadeh
Bashizadeh-Fakhar H, Rezaie-Tavirani M, Zali H, Faraji R, Kazem Nejad E, et al. The Diagnostic Value of Serum CEA, CA-125, and ROMA Index in Low-Grade Serous Ovarian Cancer. Int J Cancer Manag. 2018;11(5):e63397. doi: https://doi.org/10.5812/ijcm.63397
16
Jul
2023
Estimation Recurrence Free Survival of the Epithelial Ovarian Cancer Using Classification and Regression Tree
Maryam Deldar,
Kourosh Sayehmiri,
Robab Anbiaee,
Anahita Jalilian
Deldar M, Sayehmiri K, Anbiaee R, Jalilian A. Estimation Recurrence Free Survival of the Epithelial Ovarian Cancer Using Classification and Regression Tree. Middle East J Rehabil Health Stud. 2023;10(4):e134331. doi: https://doi.org/10.5812/mejrh-134331
12
May
2018
Comparison of Three Clinical Models for Estimating the Risk of Endometrial Cancer in Post-Menopausal Women with Abnormal Vaginal Bleeding
Shahla Yazdani,
Maryam Javadian,
Elaheh Sayarifard,
Zinatossadat Bouzari,
Meadeh Mohammadnetaj,
Azadeh Sayarifard
Yazdani S, Javadian M, Sayarifard E, Bouzari Z, Mohammadnetaj M, et al. Comparison of Three Clinical Models for Estimating the Risk of Endometrial Cancer in Post-Menopausal Women with Abnormal Vaginal Bleeding. Int J Cancer Manag. 2018;11(4):e55934. doi: https://doi.org/10.5812/ijcm.55934
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 2
Last Update: 1 week ago
- Scopus by Title (Ref): 2
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles